On top of that, the ROC curve showed that IDO had a rather high ability to predict CKD with 83.8% in sensitivity and 75% in specificity and ACR with 71.9% in sensitivity and 72.2% in specificity suggesting IDO may be a promising biomarker for assessing CKD. The gene discussed is IDO1; the disease is chronic kidney disease.